TW569010B - Bioagent automatic detection system - Google Patents

Bioagent automatic detection system Download PDF

Info

Publication number
TW569010B
TW569010B TW92113068A TW92113068A TW569010B TW 569010 B TW569010 B TW 569010B TW 92113068 A TW92113068 A TW 92113068A TW 92113068 A TW92113068 A TW 92113068A TW 569010 B TW569010 B TW 569010B
Authority
TW
Taiwan
Prior art keywords
area
image
value
test
light
Prior art date
Application number
TW92113068A
Other languages
Chinese (zh)
Other versions
TW200424526A (en
Inventor
Chen-Sheng Lin
Jau-Ying Wu
Shiou-Hua Lin
Yuan-Chin Wang
Ming-Jeng Li
Original Assignee
Oncoprobe Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncoprobe Biotech Inc filed Critical Oncoprobe Biotech Inc
Priority to TW92113068A priority Critical patent/TW569010B/en
Application granted granted Critical
Publication of TW569010B publication Critical patent/TW569010B/en
Publication of TW200424526A publication Critical patent/TW200424526A/en

Links

Landscapes

  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

A bioagent automatic detection system comprises a detection machine and a data processing device. The detection machine is installed with a rail for a bioagent moving in-and-out of the housing space of the detection machine. The housing space is illuminated by two light sources installed symmetrically and in tilt. A camera is used to take the image of a bioagent. The image is transmitted to a data processing device for image treatment. The invented system calculates the image photo intensity in the photo field measurement region between a measurement line and a control line of the bioagent in order to obtain an average gray value as a graystand, and divides the image of the measurement line into n regions. Next, the system compares the graystandard with the control line portion and the image photo field intensity threshold Tn of each region of the measurement line to determine the detection result.

Description

569010 五、發明說明(1) 【發明所屬之技術領域】 本發明係f關一種生物試劑自動檢測系統,其具有快 速、高靈敏度等^憂點。本檢測系統利用背光板特殊排列並 搭配CCD、放大叙頭與電腦等配合針對本檢測系統之創新 的影像處理法則來辨識檢測結果,以表示其反應之結果。 【先前技術】 按,C型肝炎是一種由Hepatitis c virus (HCV)而 引起的肝臟炎症。C型肝炎的傳染途徑主要是受HCV感染的 血液及體液經由皮膚或黏膜進入體内,最後進入血液。 H C V感染會引起丨交性肝炎。通常此種慢性肝炎無明顯症 狀,通常從固定的健檢中發現。C型肝炎會引起肝臟的嚴 重併發症,於感染1 5 - 2 0年後患者常因嚴重之肝硬化或肝 細胞癌而死亡。患者於感染HCV後體内會產生ant i -HCV抗 體來對抗入侵之H C V,而a n t i - H C V抗體即是生物試劑自動 檢測系統之主要偵測標的。 生物試劑自動檢測系統所採用之試劑應用免疫分析檢 驗技術及層析原理,將H C V之重組蛋白(N S 3、N S 4、N S 5、 core protein)固定在測試線位置,並以Pr〇tein g結合 膠體金作為試劑織呈色劑,主要檢測檢體内之anti—HCV抗 體(IgG、IgM、IgA)、作為快速並正確判斷人體血液是否 有受HCV感染,以幫助個人及醫師做早期的診斷。 檢體形式採用血清或血漿,在抽血後經離心處理即可 馬上進行測試。如需暫時儲存,須置於2 — 8。 C。如需長 期儲存則須置於-2 0 ° C之環境下。569010 V. Description of the invention (1) [Technical field to which the invention belongs] The present invention relates to an automatic detection system for biological reagents, which has fast, high sensitivity and other concerns. The detection system uses the special arrangement of the backlight panel, CCD, magnifying head and computer to identify the detection results and the results of the reaction. [Previous technology] According to the press, hepatitis C is an inflammation of the liver caused by Hepatitis c virus (HCV). Hepatitis C is transmitted through HCV-infected blood and body fluids through the skin or mucous membranes, and finally into the blood. H C V infection can cause sexual hepatitis. Such chronic hepatitis is usually asymptomatic and is usually found on a regular health checkup. Hepatitis C can cause severe liver complications. Patients often die from severe cirrhosis or hepatocellular carcinoma after 15-20 years of infection. After being infected with HCV, patients will produce anti-HCV antibodies to fight against the invading H C V, and the anti-H C V antibody is the main target of the biological reagent automatic detection system. The reagents used in the biological reagent automatic detection system apply immunoassay and inspection techniques and chromatography principles to fix the recombinant protein of HCV (NS 3, NS 4, NS 5, core protein) at the position of the test line, and combine with PrOtein g Colloidal gold is used as a reagent and coloring agent, mainly to detect anti-HCV antibodies (IgG, IgM, IgA) in the test body, and to quickly and correctly determine whether human blood is infected with HCV to help individuals and physicians make early diagnosis. Samples are serum or plasma, and can be tested immediately after blood extraction by centrifugation. For temporary storage, it must be stored at 2-8. C. If long-term storage is required, it must be stored at -20 ° C.

第6頁 569010 —----- —______ 五、發明說明(2) 式 速 圖 由於生化快速檢驗試劑的靈敏度遠高於傳統檢驗 因此可以克服此困莫隹,故生化快速檢驗 高靈敏度等優點。 θ $ Μ 如第1圖所示,即為一種肝炎快速檢驗試劑之示音 、、該生物試劑8具有一作用區8丄以供滴入受測: 液或體液、一個判斷試劑是否為有效品之控制線8 3 一個檢視生化反應結果之測試線8 2 ,而該控制線 = 測試線8 2所在之區域通稱為受測區域Α。若此試劊η二 格品,空制線8 3上會出現顏&,當待測血清滴 f 8 1後之生化反應結果會則呈現於測試線8 2上,俾以 藉由反應顏色來判斷血液中是否感染肝炎。 “由於生化反應係利用螢光或顏色排列、組合等,來判 斷其=之結果」而以目視法來檢測日夺,—般檢驗人員在 目測時容易因主觀的判斷而生偏差。&可以使用機器視覺 糸統辨識顏色之排列並辨識檢驗結果。而隨著生化科技的 發展與生物晶Μ、各式生化感測器等之誕生,機器視覺技 術應用於生化反應辨識與檢測已蔚為潮流,如Vi ct〇r ν Morozov等人於2 0 0 1年提出使用CCD偵測陣列式蛋白質 晶片的方法。Alberto Delgad〇於2〇〇2年提出—套MA 日日片之D N A排列查驗系統。j〇〇η μ y〇n g S ο n g等人於 20 0 2年提出使用CMOS來偵測DNA的方法。 、而由於生物試劑8上的測試線8 2通常係以滾壓塗抹 方式製成’並不具有非常良好的均勻度,且邊緣常會有模 糊現象與濃度不均勻的情形。而且測試線8 2必須斜向打Page 6569010 —----- —______ V. Description of the invention (2) Since the sensitivity of the biochemical rapid test reagent is much higher than the traditional test, this difficulty can be overcome, so the rapid sensitivity of the biochemical test is high. . θ $ Μ As shown in Figure 1, it is the indication of a rapid hepatitis test reagent, and the biological reagent 8 has an action zone 8 丄 for dripping into the test: liquid or body fluid, a judgment whether the reagent is effective The control line 8 3 is a test line 8 2 for viewing the results of the biochemical reaction, and the area where the control line = test line 82 is located is referred to as a test area A. If this test is performed on the second grade, the color & will appear on the empty line 8 3, and the biochemical reaction result after the test serum drop f 8 1 will be presented on the test line 8 2, so that the reaction color To determine if the blood is infected with hepatitis. "Because the biochemical reaction uses fluorescence or color arrangement, combination, etc. to judge its result" and to detect the sunburn by visual method, general inspectors are prone to deviations due to subjective judgment during visual inspection. & The machine vision system can be used to identify the arrangement of colors and the inspection results. With the development of biochemical technology and the birth of biological crystals and various types of biochemical sensors, machine vision technology has become a trend for the identification and detection of biochemical reactions. For example, Victor et Morozov et al. 2 0 0 One year, a method of detecting array-type protein wafers using a CCD was proposed. Alberto Delgad0 proposed in 2002 a set of D N A arrangement inspection system for MA daily films. In 2005, a method of detecting DNA using CMOS was proposed by j〇〇η μ yong g S og and others. However, because the test line 8 2 on the biological reagent 8 is usually made by a rolling application method, it does not have a very good uniformity, and the edges often have blurring and uneven concentration. And test line 8 2 must be slanted

第7頁 569010 五、發明說明(3) 光才能凸顯檢測結果,但斜向打光照射在生物試劑8的受 測區域A時,亦造成檢測影像有漸層變化之問題,因此設 置爹考光場量測區’必須措助參考光場置測區之光場強度 作為參考檢測之依據。試紙片其材質為求能與檢體穩固結 合,故造成宣紙或雲彩紙表面,檢測影像常有宣染之效果 ,帶來雜訊困擾。 這些問題都會影響以機器視覺技術來辨識生物試劑之 檢測結果的精確度,甚至導致誤判的問題。 故而,如何研究出一種能精確辨識生物試劑生化反應 結果之系統,便成為本發明之課題。 【發明内容】 本發明之主要目的,在於解決上述的問題而提供一種 以攝影機擷取生物試劑之受測區域的影像,再將生物試劑 之測試線部份的影像切割為η個區域,而能藉由比對各區 域之閥值,達到精確判斷生物試劑檢測結果之功效。 為達前述之目的,本發明之生物試劑自動檢測系統, 其包括: 一檢測機台,該檢測機台中具有一容置空間,而該檢 測機台具有一可啟閉之門,以供生物試劑進出該容置空間 5並且該檢測機台具有數個散熱孔’以供空氣流通, 一滑執,其係架設於該檢測機台之容置空間中,且該 滑軌末端設有一定位輔助桿,俾供生物試劑循該滑執進出 該容置空間,並由該定位輔助桿提供定位作用; 一光源組’其係由二光源組成’該二光源係間隔架設Page 7569010 V. Description of the invention (3) Only the light can highlight the detection result, but when the oblique light is irradiated on the test area A of the biological reagent 8, it also causes a gradual change in the detection image. The "field measurement area" must use the light field intensity of the reference light field measurement area as the basis for reference detection. The material of the test strip is to be firmly combined with the specimen, so it causes the surface of rice paper or cloud paper, and the detection image often has the effect of dyeing, which brings noise disturbance. These problems will affect the accuracy of machine vision technology to identify the detection results of biological reagents, and even cause misjudgment. Therefore, how to develop a system that can accurately identify the results of biochemical reactions of biological agents has become the subject of the present invention. [Summary of the Invention] The main object of the present invention is to solve the above-mentioned problems and provide a camera to capture the image of the tested area of the biological reagent, and then cut the image of the test line part of the biological reagent into n areas, so that By comparing the thresholds of each area, it is possible to accurately determine the efficacy of the biological reagent test result. In order to achieve the aforementioned object, the biological reagent automatic detection system of the present invention includes: a testing machine having a containing space therein, and the testing machine having an openable and closable door for biological reagents Entering and exiting the accommodating space 5 and the testing machine has several cooling holes' for air circulation, a slide handle is erected in the accommodating space of the testing machine, and a positioning auxiliary rod is provided at the end of the slide rail. , The biological reagent enters and leaves the accommodating space through the slider, and the positioning aid is provided by the positioning auxiliary rod; a light source group 'which is composed of two light sources', and the two light sources are spaced apart

569010 五、發明說明(4) 於該滑執上方對應生物試劑之受測區域處,而該二光源係 呈對稱傾斜之形態設置,且該二光源傾斜之方向係垂直於 遠滑軌之延伸方向,另於各光源上分別貼附散熱鰭片俾以 加強散熱作用; 一攝影機,其係架設於該光源組的二光源之間且對應 於生物試劑之受測區域上方; 一個以上之風扇,其係架設於該容置空間中,俾以產 生氣流將該容置空間中之熱由數個散熱孔排出; 一個資料處理裝置,其係與該攝影機連線,並對該攝 影機所取得之生物試劑影像進行影像處理,而將生物試劑 之測試線與控制線間之光場量測區的影像光場強度計算以 取得平均灰度值為基準閥值Graystandard,並將將測試線之影 像縱橫分割為η個區域,並以基準閥值Graystandard與控制線 部份及測试線各區域影像光場強度閥值τ n進行比對,任一 區域影像之平均灰度值Grayave低於區域閥值Τη時則該區域 為險性反應,並且計算所有陽性反應區域之色彩灰度平均 值Grayp ’並依據灰度平均值計算生化反應濃度之等級,若 所有區域之平均灰度值Grayave均高於區域閥值以則生物試 劑之檢測結果判定為陰性反應。 本發明之生物試劑自動檢測系統所採用之試劑應用免 疫分析檢驗技術及層析原理,將HCV之重組蛋白(NS3、 NS4、NS5、core protein)固定在測試線位置,檢體上升 至於測試線位置1 〇〜丄5分鐘,以視覺化檢測系統進 顏色判斷,經電腦取像判讀,〇 · 3秒内即可知檢測結果,569010 V. Description of the invention (4) At the measurement area corresponding to the biological reagent above the slider, the two light sources are arranged in a symmetrically inclined form, and the direction in which the two light sources are inclined is perpendicular to the extension direction of the far slide In addition, heat radiating fins are attached to each light source to enhance the cooling effect; a camera is set up between the two light sources of the light source group and corresponds to the test area of the biological reagent; more than one fan, which It is set up in the accommodating space, so as to generate airflow, the heat in the accommodating space is exhausted through several heat dissipation holes; a data processing device, which is connected with the camera and biological reagents obtained by the camera The image is subjected to image processing, and the image light field intensity of the light field measurement area between the test line and the control line of the biological reagent is calculated to obtain an average gray value as a threshold value Graystandard, and the image of the test line is vertically and horizontally divided into η regions, and compare the threshold value Graystandard with the image light field intensity threshold τ n of each area of the control line and the test line, the average gray of the image in any area When the value Grayave is lower than the regional threshold Tη, the region is a dangerous reaction, and the grayscale average value Grayp 'of all positive reaction regions is calculated, and the level of the biochemical reaction concentration is calculated based on the grayscale average. The degree Grayave is higher than the regional threshold, so that the detection result of the biological reagent is determined as a negative reaction. The reagents used in the biological reagent automatic detection system of the present invention apply immunoassay testing technology and chromatography principles to fix HCV recombinant proteins (NS3, NS4, NS5, core protein) at the position of the test line, and the specimen rises to the position of the test line 1 ~ 5 minutes, the color is judged by the visual detection system, and the image is read and interpreted by the computer. The detection result can be known within 0.3 seconds,

569010 五、 發明說明 ⑸ 靈 敏度高 且 操 作 十 分 簡 易 〇 本發 明 之 上 述 及 其 他 0 的 與 優 點 5 不 難 從 下 述 所 選 用 實 施例之 詳 細 說 明 與 附 圖 中 獲 得 深 入 了 解 〇 當然 ? 本 發 明 在 某 些 另 件 上 或 另 件 之 安 排 上 容 許 有 所 不同, 但 所 選 用 之 實 施 例 , 則 於 本 說 明 書 中 5 予 以 詳 細 說 明,並 於 附 圖 中 展 示 其 構 造 〇 [ 實施方 式 ] 請參 閱 第 1 圖 至 第 1 6 圖 , 圖 中 所 示 者 為 本 發 明 所 選 用 之貫施 例 結 構 此 僅 供 說 明 之 用 j 在 專 利 中 請 上 並 不 受 此 種結構 之 限 制 〇 本發 明 之 生 物 試 劑 動 檢 測 系 統 5 其 包 括 了 硬 體 的 一 檢 測機台 1 部 份 與 軟 體 的 一 資 料 處 理 裝 置 部 份 〇 該檢 測 機 台 1 中 具 有 一 容 置 空 間 1 1 j 而 該 檢 測 機 台 1 具有一 可 啟 閉 之 門 1 2 ? 以 供 生 物 試 劑 8 進 出 該 容 置 空 間 11, 並 且 該 檢 測 機 台 1 兩 侧 分 別 具 有 數 個 散 熱 孔 1 3 以供空 氣 流 通 〇 * 該檢 測 機 台 1 之 容 置 空 間 1 1 中 ri-Π. δ又 有 • 一滑 軌 1 4 5 其 係 架 δ又 於 該 檢 測 機 台 1 之 容 置 空 間 1 1 中,且 該 滑 軌 1 4 末 端 設 有 一 定 位 輔 助 桿 1 4 1 俾 供 生 物試劑 8 循 該 滑 執 1 4 進 出 該 容 置 空 間 1 1 並 由 該 定 位 輔助桿 1 4 1 提 供 定 位 作 用 〇 一光 源 組 其 係 由 二 光 源 1 5 組 成 於 本 實 施 例 中 , 光 源係採 用 黃 光 之 背 光 板 1 該 二 光 源 1 5 係 間 隔 架 ^rTL δ又 於 該 滑 軌1 4 上 方 對 應 生 物 試 劑 8 之 受 測 區 域 A 處 而 該 一" 光569010 V. Description of the invention 高 High sensitivity and very simple operation. The above and other advantages and advantages of the present invention 5 It is not difficult to obtain a deep understanding from the detailed description and drawings of the selected embodiment below. Of course? Some of the parts or arrangements of other parts are allowed to be different, but the selected embodiment is described in detail in this specification, and its structure is shown in the drawings. [Embodiment] Please refer to Figure 1 To the 16th figure, the structure shown in the figure is the selected embodiment of the structure of the present invention. This is for illustration only. In the patent, please do not limit this structure. The biological reagent dynamic detection system of the invention 5 It includes a testing machine 1 part of the hardware and a data processing device part of the software. There is an accommodating space 1 1 j, and the testing machine 1 has a door 12 that can be opened and closed for biological reagents 8 to enter and leave the accommodating space 11, and the testing machine 1 has several cooling holes 1 on both sides of the testing machine 1. 3 for air circulation. 0 * The accommodating space 1 1 of the inspection machine 1 has ri-Π. Δ again. • There is a slide rail 1 4 5 The frame δ is in the accommodating space 1 of the inspection machine 1 1 1 A positioning aid rod 1 4 1 is provided at the end of the slide rail 1 4 for biological reagents 8 Follow the slider 1 4 to enter and leave the accommodation space 1 1 and provide positioning function by the positioning assistance rod 1 4 1 The group is composed of two light sources 1 5 in this embodiment, and the light source is a yellow light backlight plate 1. The two light sources 15 are a spacer ^ rTL δ and correspond to the test area A of the biological reagent 8 above the slide rail 1 4 To be " light

第ίο頁 569010 五、發明說明(6) 源1 5係呈對稱傾斜之形態設置,且該二光源1 5傾斜之 方向係垂直於該滑執1 4之延伸方向,另於各光源1 5上 分別貼附散熱鰭片1 5 1俾以加強散熱作用。 一攝影機1 6 ,其係架設於該先源組的二光源i 5之 間且對應於生物試劑8之受測區域a上方。 二個風扇1 7 ,其係架設於該容置空間1 1對於檢測 機台1兩侧散熱孔1 3處’俾以產生氣流將該容置空間1 1中之熱由數個散熱孔1 3排出。 該資料處理裝置3係與該攝影機1 6連線,並對該攝 衫機1 6所取得之生物試劑8影像進行影像處理,而將生 物試劑8之測試線8 2與控制線8 3間之光場量測區B的 影像光場強度計算以取得平均灰度值為基準閥值Graystandard ’並將將測試線8 2之影像縱橫分割為^個區域C,並以 基V閥值Gray^㈣^^與控制線檢驗區d及測試線8 2各區域 C影像光場強度閥值τ η進行比對,任一區域c影像之平均 灰度值Grayave低於區域閥值Τη時則該區域c為陽性反應, 並且計算所有陽性反應區域之色彩灰度平均值Grayp,並依 據灰度平均值計算生化反應濃度之等級,若所有區域之平 均灰度值Grayave均南於區域閥值^則生物試劑之檢測結果 判定為陰性反應。 以攝影機1 6攝取生物試劑8之影像時,首先需克服 像雜訊問題,本發明係採取平均連續多張影像以抑制雜訊 之方式。 °Page 569569010 V. Description of the invention (6) The source 15 is symmetrically inclined, and the direction of the two light sources 15 is perpendicular to the extension direction of the slider 14 and on the light sources 15 Attach heat sink fins 1 5 1 俾 to enhance heat dissipation. A camera 16 is set up between the two light sources i 5 of the first source group and corresponds to the measurement area a of the biological reagent 8. Two fans 17 are set up in the accommodating space 1 1 for the heat dissipation holes 13 on both sides of the testing machine 1 to generate airflow, and the heat in the accommodating space 11 is divided into a plurality of heat dissipation holes 1 3 discharge. The data processing device 3 is connected to the camera 16 and performs image processing on the image of the biological reagent 8 obtained by the camera 16, and between the test line 8 2 and the control line 8 3 of the biological reagent 8 The light field intensity of the image in the light field measurement area B is calculated to obtain an average gray value as a reference threshold Graystandard, and the image of the test line 8 2 is vertically and horizontally divided into ^ regions C, and the base V threshold is Gray ^ ㈣ ^^ Compare with the control line inspection area d and test line 8 2 in each area C image light field intensity threshold τ η. If the average gray value of the image in any area c is Grayave is lower than the area threshold τn, the area c It is a positive reaction, and calculates the grayscale average value Grayp of all positive reaction areas, and calculates the level of the biochemical reaction concentration based on the average grayscale value. If the average grayscale value of all areas in the area is Grayave south of the area threshold ^, the biological reagent The test result was judged as a negative reaction. When taking the image of the biological reagent 8 with the camera 16, it is necessary to overcome the noise problem first. The present invention adopts a method of averaging multiple consecutive images to suppress the noise. °

第11頁 569010 五、發明說明(7) L&v&i 其中S ( X,Y)為影像之訊號值;Ni ( X,Y)第i次取像 之雜訊大小假設第i次取像之整體雜訊為隨機分佈,整體 影像之雜訊值可表示為Zeve/Page 11569010 V. Description of the invention (7) L & v & i where S (X, Y) is the signal value of the image; the noise level of the i-th image acquisition of Ni (X, Y) is assumed to be the i-th image acquisition The overall noise is randomly distributed. The noise value of the overall image can be expressed as

影像之訊雜比如下 L&v&I 影像經過Μ次取像,再求取其平均值 _ I ΜThe image miscellaneous image is as follows: L & v & I image is taken M times, and then its average value _ I Μ

其中Gray i ( X,Y )為各幅單點之灰度值;Μ為影像幅數經過 推導之後,可得Among them, Gray i (X, Y) is the gray value of each single point; M is the number of images.

a/MxSNR 即影像經過Μ次取像之後,影像之訊雜比將提高 ^倍,抑 制了雜訊,參考第6圖所示。a / MxSNR means that after the image has been acquired M times, the noise-to-noise ratio of the image will be increased by ^ times, and the noise is suppressed. Refer to Figure 6 for reference.

再者,由於生物試劑8上的測試線8 2通常係以滚壓 塗抹方式製成,並不具有非常良好的均勻度,且邊緣常會 有模糊現象與濃度不均勻的情形。為克服此一問題,本發 明係將攝影機1 6所取得的影像(如第7圖所示)進行下列 的運算: 二值化之影像 A被B蝕刻之運算可表示如下: ΑΘΒ = {χ(Β)χ^Α}In addition, since the test line 8 2 on the biological reagent 8 is usually made by roll coating, it does not have very good uniformity, and the edges often have blurring and uneven concentration. To overcome this problem, the present invention performs the following operations on the image obtained by the camera 16 (as shown in FIG. 7): The operation that the binary image A is etched by B can be expressed as follows: ΑΘΒ = {χ ( Β) χ ^ Α}

第12頁 569010 五、發明說明(8) 有灰階之影像f 與b之之蝕刻運算其數學式可表示如 下: ίβφ , t) = min{f(x+s , i + y)-b(x , :φ+χ) , (^+¥) ; (χ , >〇ε 其中,Df和Db為f與b之區域。 如果退化成為一個變數之函數時,上式變為: (fBh)(s) = min{ f(s + x)- ά(χ)|(^ + χ) ε Ζ?/ 和 xe 其中Β為一 6*1範圍之内容為1的遮罩 更進一步說,當測試線8 2有明顯的反應現象時,便 會在第7圖之生物試劑8受測區域Α的影像中可以清楚看 出測試線8 2與控制線8 3間之光場量測區B影像上的差 異,而第8圖則是將第7圖之影像反轉運算後,轉換成3D 立體圖形之形態,但是當測試線8 2沒有明顯的反應現象 時,如第9圖所示之生物試劑8受測區域A的影像,便不 易判定測試線8 2的確實位置,此時,便可經由前述的運 算取得第1 0圖與第1 1圖所示之資料,而能清楚地判斷 測試線8 2的確貫位置。 接下來便依序進行下列工作。 1 ·檢測控制線8 3是否正常 於控制線8 3檢驗區D中檢驗控制線8 3是否工作正 常。 2 ·計控制線8 3之幾何中心位置,並估測測試線8 2與 光場置測區A之位置。Page 12569010 V. Description of the invention (8) The mathematical expression of the etching operation of gray image f and b can be expressed as follows: ίβφ, t) = min {f (x + s, i + y) -b ( x,: φ + χ), (^ + ¥); (χ, > 〇ε where Df and Db are the regions of f and b. If degradation becomes a function of a variable, the above formula becomes: (fBh) (s) = min {f (s + x)-ά (χ) | (^ + χ) ε Z? / and xe where B is a mask with a content of 1 in the range of 6 * 1. Further, when testing When the line 8 2 has an obvious reaction phenomenon, it can be clearly seen on the image of the light field measurement area B between the test line 8 2 and the control line 8 3 in the image of the test area A of the biological reagent 8 in FIG. 7. Figure 8 is the result of inverting the image of Figure 7 into a 3D three-dimensional figure, but when the test line 8 2 has no obvious reaction phenomenon, as shown in Figure 9 biological reagents It is difficult to determine the exact position of the test line 8 2 in the image of the tested area A. At this time, the data shown in Figures 10 and 11 can be obtained through the aforementioned calculations, and the test line can be clearly determined. 8 2 is indeed consistent position. The following tasks are performed in order: 1 · Check whether the control line 8 3 is normal to the control line 8 3 In the inspection area D, check whether the control line 8 3 is working normally. 2 · Calculate the geometric center position of the control line 8 3 and estimate the test line 8 2 and the location of the light field measurement area A.

569010 之幾何中 ;測試線 測試線8 場夏測區 線8 2檢 場變化, 光場量測 與攝影機 有偏移之 2檢驗區 異量,如 便有差異 之閥值, 中每個分 = 1 〜·30 驗時,外 ,故需要 驗環境之 Β之平均 驗區中閥 自動調整 之值應為 感光晶片 現象發生 中每個分 第1 2圖 存在。故 以減少因 割區域的 ,光場量 ,置為Pc ;光場量測區A 2幾U何中心位置為P“ °中心距離差為△d。 在環境 對幾個 變化程 灰度值 值之基 閥值 固定, 的色漂 。又光 割區域 所示, 可依據 光源而 閥值為 測區與 五、發明說明(9) 假設控制線8 3 之幾何中心位置為P i 估測之控制線8 3與 Μ 則 ; 3 ·光場量測 為了嫁保每次檢 低干擾所產生之誤差 強度量測,以掌握檢 假設光 值作為測試 4 ·依據光 理論上 強度之誤差 像整體色彩 與測試線8 乎固定之差 的光場強度 整分割區域 试線檢驗區 均灰度值為 異量為吒, ,素均保持固定,降 特定位置之光場作光 度。 為 ,並以此 準。 但因為光源系統打光 現象,造成掏取之影 場量測隱之光場強度 C的光場強度均有近 區域c 1與區域c ^ 光場之變化’自動調 產生之誤差。假設測 及;光碭量測區之平 分割區城之光強度差In the geometry of 569010; test line test line 8 field summer measurement area line 8 2 detection field change, the light field measurement is offset from the camera 2 inspection area difference, if there is a threshold difference, each point = 1 ~ · 30 In the inspection, the value of the automatic adjustment of the valve in the average inspection zone of the environment B that needs to be inspected should be the existence of each of the points in Figure 12 during the occurrence of the photosensitive wafer phenomenon. Therefore, in order to reduce the cutting area, the light field amount is set to Pc; the light field measurement area A 2 and the center position of P 2 ° and the center distance difference is Δd. In the environment, the gray value of several changes in range The base threshold value is fixed, and the color drift is shown in the light cut area. The threshold value can be measured according to the light source. V. Explanation of the invention (9) Assuming that the geometric center position of the control line 8 3 is the control estimated by P i Line 8 3 and Μ rules; 3. Light field measurement In order to guarantee the error intensity measurement produced by each detection of low interference, the light value of the detection hypothesis is used as the test 4 · According to the theoretical error of light intensity, the overall color and Test line 8 The light field intensity of the fixed difference is a fixed area. The average gray value of the test line inspection area is different, and the primes are kept fixed. The light field at a specific position is lowered as the lightness. However, because of the lighting phenomenon of the light source system, the hidden light field intensity C of the extracted light field measurement has the light field intensity of the near area c 1 and the area c ^ light field changes' automatic adjustment error. It is assumed that ; Light intensity difference of city in flat divided area of light measurement area

第14頁 569010 五、發明說明(ίο) 」?2 -‘·standard + , f"J = 1 ·—· 30 5 ·檢測生物試劑之測試線 於本實施例中,係將測試線8 2檢驗區分為3 0個小 區域’每個小區域依光場不同而設定不同之閥值’用以檢 驗測試線8 2是否發生反應。又檢驗區裡分割區域C中陽 性反應的像素點數目常會有小於陰性反應之像素點數目之 情況發生,為了避免分割區域C之平均灰度值被誤判為陰 性反應’故在計算分割區域C之平均灰度值時,將增加可 能為陽性反應之像素灰度權重值,以提高判斷之準確度。 假設區域閥值尺,Η =1〜30 ;區域平均灰度值;小 於區域閥值之像素灰度值;小於區域閥值之像 素數目施〃〗“;小於區域閥值之像素灰度權重值大於 區域閥值之像素灰度值^蝴(X,幻;大於區域閥值之像素 數目施爪_ 0Page 14569010 V. Description of the invention (? Ο) 2-'· standard +, f " J = 1 ··· 30 5 · Test line for detecting biological reagents In this example, the test line 8 2 is tested Divided into 30 small areas 'Each small area sets a different threshold depending on the light field' to test whether the test line 8 2 reacts. In addition, the number of pixels with positive reactions in the segmented area C in the inspection area often is smaller than the number of pixels with negative reactions. In order to avoid the average gray value of the segmented area C being misjudged as a negative reaction, When the gray value is averaged, the gray value of the pixel that may be a positive response will be increased to improve the accuracy of the judgment. Assume the area threshold rule, Η = 1 ~ 30; the area average gray value; the gray value of the pixel less than the area threshold; the number of pixels less than the area threshold; Gray value of pixels greater than regional threshold ^ Butterfly (X, magic; number of pixels greater than regional threshold

GmytGmyt

Num^ +Num ^ +

GraykJ^y、S < GrnyGraykJ ^ y, S < Grny

6 ·判斷反應結果 當檢驗區中有任一分割區域之反應顏色Gr吵⑽低於區 域閥值、,π = 1〜30 ,則為陽性反應,並且計算所有陽性6 · Judging the reaction result When the reaction color Gr of any of the divided areas in the test area is lower than the area threshold, and π = 1 ~ 30, it is a positive reaction, and all positives are calculated.

第15頁 569010 五、發明說明οι) 反應區域之色彩灰度平均值P,並依據灰度平均值計 算生化反應濃度之等級。若全無反應,則判定為陰性反應 陽性反應: 假設有個分割區域呈現陽性反應;呈陽性反應之 分割區域反應顏色;區域閥值7;, η =1~30 ;所有 陽性反應區域之色彩灰度平均值光場量測區之平 均灰度值為^ ;生化反應濃度之等級為Ζ.抑d ;等級 間隔為ηPage 15 569010 V. Description of the invention ο) The average gray value P of the color in the reaction area, and the level of the biochemical reaction concentration is calculated based on the average gray value. If there is no response, it is judged as a negative reaction. Positive reaction: Assume that there is a segmented area showing a positive response; the color of the segmented area showing a positive response; the area threshold 7 ;, η = 1 ~ 30; the color of all positive reaction areas is gray. The average gray value of the measurement area of the average light field is ^; the grade of the biochemical reaction concentration is Z. d; the grade interval is η

LevelLevel

Num ,where 施〜>〇 and <7; 陰性反應: 陰性區域之平均灰度值均高於區域間值,則為 本發明在HCV試劑檢測結果有二 1 ·=性,應(Posltive):有—種 w" <久自ώ = ^ f為控制線出現色帶,且同時測試線亦同時 七各自出現色帶時,表示受測者血、、主φ器右ΑηΗ 广 體。色帶顏色之、、菜、叮也主人=血,月中f有Antl—HCV之抗 汽低。 /衣次可代表血清中抗體效價(t i ter )之Num, where to apply ~> 0 and <7; Negative reaction: The average gray value of the negative area is higher than the inter-area value, then the detection result of the HCV reagent according to the present invention has 2 1 ==, should (Posltive) : There is a kind of w " < Jiu Zijian = ^ f indicates that the control line appears with a color band, and at the same time the test line also appears with a color band at the same time, indicating that the test subject's blood, and the main device are wide. The color of the ribbon, the dish, the bite is also the owner = blood, the f of the month has Antl-HCV and the anti-steam is low. / Clothing times can represent the antibody titer (t i ter) in serum

第16頁 569010 —-~~~~~~一__________ 五、發明說明(12) 2 ·陰性反應(Negative): 當測試結果為僅控制線出現色帶時,表示受測者血 清中不含Anti-HCV之抗體。 3 ·無反應(Invalid): 如果測試結果未出現任何色帶或是控制線未出現色帶 ’此時表示此試劑已失效、過期,或操作不當,需另做一 次測試。 本發明之資料處理裝置3係為可一個人電腦,影像透 過USB2.0傳輸介面(傳輸速率高達48 0Mbps)接收至電腦 ,利用本發明所提出之自動化視覺檢測法則,可即時辨識 生化反應,判斷是否為陽性反應或陰性反應。若為陽性反 應,則進而計算反應濃度之等級,提供客觀、精準之數據 ’以作為醫護人員診斷C型肝炎時之重要依據。在操作方 面’使用者只需將待測之生物試劑8置於檢測機台1之滑 執1 4中,再按下資料處理裝置3之軟體中開始檢測之按 紐’系統會自動辨識生化反應,並將結果輸出至表格中, 且在影像中標示出陽性反應之區域位置。如第1 3圖所示 為檢測出陰性反應之結果;如第1 4圖至第1 6圖所示, 則為檢測出陽性反應之結果。其中·. 弟1 4 SI係顯不生化反應丨辰度寻級丨=5 0之狀態。 第1 5圖係顯示生化反應濃度等級上_; = 7 5之狀態。 第1 6圖係顯示生化反應濃度等級以㈣=1 〇 〇之狀態。 綜上所述,本發明以攝影機1 6擷取生物試劑8之受Page 16569010 —- ~~~~~~ One __________ 5. Explanation of the invention (12) 2 · Negative: When the test result shows that only the control line shows a color band, it means that the test subject's serum does not contain Anti-HCV antibodies. 3 · Invalid: If there is no color band in the test result or no color band appears on the control line ’this means that the reagent has expired, expired, or operated improperly, and another test is required. The data processing device 3 of the present invention can be a personal computer, and the image is received to the computer through a USB2.0 transmission interface (the transmission rate is up to 4800 Mbps). Using the automatic visual inspection rule proposed by the present invention, the biochemical reaction can be identified in real time to determine whether Positive or negative. If it is a positive response, then the level of the reaction concentration is calculated to provide objective and accurate data ′ as an important basis for medical personnel to diagnose hepatitis C. In terms of operation, the user only needs to place the biological reagent 8 to be tested in the slide 1 of the testing machine 1 and then press the button in the software of the data processing device 3 to start the detection. The system will automatically recognize the biochemical reaction , And output the result to the table, and mark the area of the positive reaction in the image. As shown in Figure 13 is the result of detecting a negative reaction; as shown in Figures 14 to 16 is the result of detecting a positive reaction. Among them. Brother 1 4 SI system shows no biochemical reaction 丨 Chen degree grading 丨 = 50 state. Figure 15 shows the state of _; = 75 in the biochemical reaction concentration level. Fig. 16 shows a state in which the concentration level of the biochemical reaction is ㈣ = 1 00. In summary, the present invention uses a camera 16 to capture the biological agent 8

569010 五、發明說明(13) 測區域A的影像,再將生物試劑8之測試線8 2部份的影 像切割為η個區域,而能藉由比對各區域之閥值,達到精 確判斷生物試弹丨檢測結果之功效。 以上所述實施例之揭示係用以說明本發明,並非用以 限制本發明,故舉凡數值之變更或等效元件之置換仍應隸 屬本發明之範疇。 由以上詳細說明,可使熟知本項技藝者明瞭本發明的 確可達成前述目的,實已符合專利法之規定,爰提出專利 申請。569010 V. Description of the invention (13) Measure the image of area A, and then cut the image of part 2 of the test line 8 of biological reagent 8 into n areas. By comparing the thresholds of each area, the biological test can be accurately judged. The effectiveness of the test results. The disclosure of the embodiments described above is used to illustrate the present invention, and is not intended to limit the present invention. Therefore, any change in the value or replacement of equivalent components should still belong to the scope of the present invention. From the above detailed description, those skilled in the art can understand that the present invention can indeed achieve the aforementioned purpose, and it has indeed complied with the provisions of the Patent Law, and filed a patent application.

第18頁 569010 圖式簡單說明 【圖式簡單說明】 第1圖係生物試劑之外觀示意圖 第2圖係本發明之檢測系統之配置示意圖 第3圖係本發明檢測機台内之結構示意圖之一 第4圖係本發明檢測機台内之結構示意圖之二 第5圖係本發明之生物試劑影像檢測區域之示意圖 第6圖係本發明濾除雜訊時之多幅單點示意圖 第7圖係本發明攝影機所取得生物試劑一之影像 第8圖係本發明中生物試劑一影像的立體座標值 第9圖係本發明攝影機所取得生物試劑二之影像 第1 0圖係本發明中生物試劑二影像的立體座標值 第1 1圖係本發明中生物試劑二影像經二值化運算後 求得之二值化數值圖 第1 2圖係本發明中之光場分佈示意 第1 3圖係本發明檢測出陰性反應結果之顯示晝面 第1 4圖係本發明檢測出陽性反應生化反應濃度等級 iewi = 5 0狀態之顯示畫面 第1 5圖係本發明檢測出陽性反應生化反應濃度等級 = 7 5狀態之顯示晝面 第1 6圖係本發明檢測出陽性反應生化反應濃度等級 ώνβ = 1 0 0狀態之顯示畫面 【圖號說明】Page 18569010 Brief description of the drawings [Simplified description of the drawings] Figure 1 is a schematic diagram of the appearance of a biological reagent. Figure 2 is a schematic diagram of the configuration of the detection system of the present invention. Figure 3 is one of the schematic diagrams of the structure of the testing machine of the present invention. Figure 4 is the second schematic diagram of the structure of the testing machine of the present invention. Figure 5 is the schematic diagram of the biological reagent image detection area of the present invention. Figure 6 is the single-point schematic diagram of the present invention when filtering out noise. Image 8 of the biological reagent 1 obtained by the camera of the present invention. Figure 8 is the three-dimensional coordinate value of the image of the biological reagent 1 obtained by the camera of the present invention. Figure 9 is the image of the biological reagent 2 obtained by the camera of the present invention. The three-dimensional coordinate values of the image. Figure 1 is a binary value figure obtained after the binary image of the biological reagent in the present invention is obtained through a binary operation. Figure 12 is a schematic diagram of the light field distribution in the present invention. Display of the day when the negative reaction result is detected in the invention. Figure 14 shows the concentration level of the biochemical reaction when the positive reaction is detected by the present invention, iewi = 50. The display screen in the state of Figure 15 shows the result of the biochemical detection of the positive reaction by the present invention. = Density level should display surface of the first day 16 the state of FIG. 75 positive biochemical reaction system ώνβ = concentration level state of the display screen 100 [FIG No. Description The present invention is detected

第19頁 569010 圖式簡單說明Page 19 569010 Schematic description

滑軌1 4 光源1 5 攝影機1 6 資料處理裝置3 作用區8 1 控制線8 3 光場量測區B 控制線檢驗區D 定位辅助桿1 4 1 散熱鰭片1 5 1 風扇1 7 生物試劑8 測試線8 2 受測區域A 區域 C、C 1 、C 2Slide rail 1 4 Light source 1 5 Camera 1 6 Data processing device 3 Operating area 8 1 Control line 8 3 Light field measurement area B Control line inspection area D Positioning auxiliary rod 1 4 1 Radiating fin 1 5 1 Fan 1 7 Biological reagent 8 Test line 8 2 Test area A Area C, C 1, C 2

第20頁Page 20

Claims (1)

569010 六、申請專利範圍 1 · 一種生物試劑自動檢測系統,其包括: 一檢測機台,該檢測機台中具有一容置空間,而 該檢測機台具有一可啟閉之門,以供生物試劑進出該 容置空間,並且該檢測機台具有數個散熱孔,以供空 氣流通; 一滑執,其係架設於該檢測機台之容置空間中, ,且該滑軌末端設有一定位輔助桿,俾供生物試劑循 該滑執進出該容置空間,並由該定位辅助桿提供定位 作用; 一光源組,其係由二光源組成,該二光源係間隔 架設於該滑軌上方對應生物試劑之受測區域處,而該 二光源係呈對稱傾斜之形態設置,且該二光源傾斜之 方向係垂直於該滑執之延伸方向,另於各光源上分別 貼附散熱鰭片俾以加強散熱作用; 一攝影機,其係架設於該光源組的二光源之間且 對應於生物試劑之受測區域上方; 一個以上之風扇,其係架設於該容置空間中,俾 以產生氣流將該容置空間中之熱由數個散熱孔排出; 一個資料處理裝置,其係與該攝影機連線,並對 該攝影機所取得之生物試劑影像進行影像處理,利用 一 6 * 1範圍内容為1之遮罩作#刻運算,以消除試劑 上宣染效果之雜訊,並依序進行下列工作; (1 )·檢測控制線是否正常 於控制線檢驗區中檢驗控制線是否工作正常;569010 VI. Scope of patent application1. An automatic biological reagent detection system, which includes: a testing machine, the testing machine has an accommodation space, and the testing machine has a door that can be opened and closed for biological reagents Enter and exit the accommodating space, and the testing machine has several cooling holes for air circulation; a sliding handle, which is erected in the accommodating space of the testing machine, and a positioning aid is provided at the end of the slide rail. A rod for the biological reagent to enter and exit the accommodation space through the slider, and the positioning auxiliary rod provides the positioning function; a light source group, which is composed of two light sources, which are spaced apart from the corresponding biological above the slide rail At the test area of the reagent, the two light sources are arranged symmetrically and inclined, and the direction in which the two light sources are inclined is perpendicular to the extending direction of the slider. In addition, heat radiation fins 贴 are attached to each light source to strengthen it. Radiating effect; a camera is set between two light sources of the light source group and corresponds to a test area of biological reagents; more than one fan is set in the In the installation space, the heat in the accommodation space is exhausted through several heat dissipation holes to generate airflow. A data processing device is connected to the camera and image-processes the biological reagent image obtained by the camera. Use a mask with a range of 1 in the range of 6 * 1 to perform the #engraving operation to eliminate the noise of the dyeing effect on the reagent, and perform the following tasks in order; (1) · Check whether the control line is normal in the control line inspection area Check whether the control line works normally; 第21頁 569010 六、申請專利範圍 (2 )·計算控制線之幾何中心位置,並估測測試線與 光場量測區A之位置 將生物試劑之測試線與控制線間之光場量測區的 影像光%強度計算以取得平均灰度值為基準閥值 Graystandard ’並將將測試線之影像縱橫分割為個區域 ’並以基準閥值Graystandard與控制線部份及測試線各區 域影像光%強度閥值Τ η進行比對,任一區域影像之平 均灰度值Grayave低於區域閥值Τη時則該區域為陽性反 應,並且計算所有陽性反應區域之色彩灰度平均值 Grayp,並依據灰度平均值計算生化反應濃度之等級, 右所有區域之平均灰度值Grayave均高於區域閥值^^則 生物試劑之檢測結果判定為陰性反應; 其中判斷與處理法則如不: (1 )各區域之光場強度閥值以與光場量測區之光場強 度間存在之固定的差異量為ω η,則各區域之光 場強度閥值Τη =基準閥值Graystandard+ ω ^,該資 料處理裝置便會據此計算出各區域之閥值Τη,再 以計算出之各區域閥值Τη與測試線之影像光場強 度進行比對,俾以減少因光源而產生之誤差; (2 )該資料處理裝置所欲求得之各區域平均灰度值 Grayave,小於區域閥值之像素灰度值Grayi〇w ( X,乂 ):小於區域閥值之像素數目NumlQW ;小於區域閥 值之像素灰度權重值ω ;大於區域閥值之像素灰 度值Grayhigh ( X,y );大於區域閥值之像素數目Page 21 569010 VI. Patent application scope (2) · Calculate the geometric center position of the control line, and estimate the position of the test line and the light field measurement area A. Measure the light field between the test line of the biological reagent and the control line. Area image light% intensity calculation to obtain the average gray value as the threshold value Graystandard 'and divide the test line image horizontally and vertically into regions' and use the threshold value Graystandard and the control line part and each area of the test line image light The% intensity threshold τ η is compared. When the average gray value Grayave of any area image is lower than the area threshold τn, the area is a positive reaction, and the average gray level grayp of all positive reaction areas is calculated. The average value of the gray level is used to calculate the level of the biochemical reaction concentration. The average gray value of Grayave in all the areas on the right is higher than the threshold value of the area ^^ The detection result of the biological reagent is judged as a negative reaction; if the judgment and processing rules are not: (1) The threshold value of the light field intensity of each area is equal to the fixed difference between the light field intensity of the light field measurement area and ω η. Then, the light field intensity threshold value of each area τη = the reference valve. If the value is Graystandard + ω ^, the data processing device will calculate the threshold value τη of each area accordingly, and then compare the calculated threshold value τη of each area with the image light field intensity of the test line to reduce the The error produced; (2) The average gray value of each region desired by the data processing device, Grayave, is less than the regional threshold value of the gray value of the pixel, Grayi0w (X, 乂): the number of pixels smaller than the regional threshold value, NumlQW; Grayscale weight value ω of the pixel smaller than the regional threshold; Grayhigh (X, y) of the gray value of the pixel larger than the regional threshold; the number of pixels larger than the regional threshold 569010 六、申請專利範圍 N U m high ?則區域平均度值為 ,其中 Omy^ix.y)^ <〇Γ〇γ^9ν) ,藉此增加可能為 陽性反應之像素灰度權重值,以提高判斷之準確 度; (3)該資料處理裝置計算生化反應濃度等級Level 广一, 'Σ Gray - 之公式係 ^ = 报洲、,其中施% >0, Gray^ <7; ,而Nump係為呈現陽性反應之區塊數量,η為生化反 應濃度等級間隔。 2 ·依申請專利範圍第1項所述之生物試劑自動檢測系統 ,其中該光源組之各光源係採用黃光之背光板。 3 ·依申請專利範圍第1項所述之生物試劑自動檢測系統 ,其中該檢測機台的兩側均具有數個散熱孔,且該容 置空間中靠近檢測機台兩侧之散熱孔處分別設有一風 扇。569010 VI. The scope of patent application NU m high? The regional average degree value, where Omy ^ ix.y) ^ < 〇Γ〇γ ^ 9ν), thereby increasing the grayscale weight value of the pixel that may be a positive reaction, to Improve the accuracy of judgment; (3) The data processing device calculates the concentration level of biochemical reaction Level Hiichi, 'Σ Gray-The formula is ^ = Bao Zhou, where% > 0, Gray ^ <7;, and Nump is the number of blocks showing a positive reaction, and η is the interval of concentration levels of biochemical reactions. 2. The biological reagent automatic detection system according to item 1 of the scope of the patent application, wherein each light source of the light source group is a yellow light backlight board. 3. The biological reagent automatic detection system according to item 1 of the scope of the patent application, wherein both sides of the detection machine have several heat dissipation holes, and the accommodation space is close to the heat dissipation holes on both sides of the test machine, respectively. Equipped with a fan. 第23頁Page 23
TW92113068A 2003-05-13 2003-05-13 Bioagent automatic detection system TW569010B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW92113068A TW569010B (en) 2003-05-13 2003-05-13 Bioagent automatic detection system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW92113068A TW569010B (en) 2003-05-13 2003-05-13 Bioagent automatic detection system

Publications (2)

Publication Number Publication Date
TW569010B true TW569010B (en) 2004-01-01
TW200424526A TW200424526A (en) 2004-11-16

Family

ID=32591172

Family Applications (1)

Application Number Title Priority Date Filing Date
TW92113068A TW569010B (en) 2003-05-13 2003-05-13 Bioagent automatic detection system

Country Status (1)

Country Link
TW (1) TW569010B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI609352B (en) * 2015-09-29 2017-12-21 美和學校財團法人美和科技大學 Method of color identification for paper-based analytical devices
EP3527972A1 (en) * 2018-02-19 2019-08-21 Roche Diabetes Care GmbH Method and devices for performing an analytical measurement
TWI715075B (en) 2019-06-24 2021-01-01 瑞昱半導體股份有限公司 Skin tone image gamut weight detecting method and device thereof

Also Published As

Publication number Publication date
TW200424526A (en) 2004-11-16

Similar Documents

Publication Publication Date Title
Kitahara et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations
Goel et al. Accuracy of MRI in prediction of tumour thickness and nodal stage in oral tongue and gingivobuccal cancer with clinical correlation and staging
Chang et al. Clinical-guide risk prediction of hepatocellular carcinoma development in chronic hepatitis C patients after interferon-based therapy
Izzo et al. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis
Lin et al. Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B
Poustchi et al. Transient elastography in hepatitis C virus‐infected patients with beta‐thalassemia for assessment of fibrosis
Joo et al. Prospective comparison of noninvasive fibrosis assessment to predict advanced fibrosis or cirrhosis in Asian patients with hepatitis C
Shimizu et al. Sequential fluctuation pattern of serum des-γ-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis
Li et al. Development of algorithms based on serum markers and transient elastography for detecting significant fibrosis and cirrhosis in chronic hepatitis B patients: Significant reduction in liver biopsy
Fujita et al. Correlation between serum galectin‐9 levels and liver fibrosis
Ou et al. MRI arterial enhancement fraction in hepatic fibrosis and cirrhosis
de Monyé et al. Observer dependency of the SimpliRed D-dimer assay in 81 consecutive patients with suspected pulmonary embolism
Schöniger-Hekele et al. The combined elevation of tumor markers CA 19-9 and CA 125 in liver disease patients is highly specific for severe liver fibrosis
Salem et al. Clinical significance of plasma osteopontin level as a biomarker of hepatocellular carcinoma
TW569010B (en) Bioagent automatic detection system
Wang et al. Ultrasonographic quantification of hepatic–renal echogenicity difference in hepatic steatosis diagnosis
Shibata et al. Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease
Mendes et al. Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C
Shibata et al. Liver stiffness‐spleen size‐to‐platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C
Mehinovic et al. Evaluation of diagnostic efficiency of alpha-fetoprotein in patients with liver cirrhosis and hepatocellular carcinoma: single-center experience
Schor et al. Heterogeneity in microvascular density in lung tumours: comparison with normal bronchus
Sellors et al. Assessment of the cervix after acetic acid wash: inter-rater agreement using photographs
Zhang et al. Predict esophageal varices via routine trans‐abdominal ultrasound: A design of classification analysis model
Hidaka et al. Reliability and validity of splenic volume measurement by 3‐D ultrasound
Choi et al. Detecting early hepatocellular carcinoma in patients with chronic hepatitis B using longitudinal α-fetoprotein screening

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees